SMi's 10th annual Clinical Trials in CNS, 23rd & 24th November 2011
/EINPresswire.com/ SMi's 10th annual Clinical Trials in CNS conference will be an ideal platform for leading industry experts to discover the current and future opportunities within the essential field of CNS drug development. This conference will address current clinical drug discovery activities, as well as innovative and effective drug development strategies and potential problems often faced in clinical trials.
This conference will focus on a wide range of therapeutic areas such as Multiple Sclerosis, Parkinson's and Alzheimer's, as well as considering a multitude of psychiatric disorders with in-depth discussions and case study presentations from the key industry players.
As such a fast-progressing and important field, it is vital that you are kept up to date with the latest developments and advances in CNS Clinical Trials, such as novel translational research studies. This conference will offer a unique opportunity for you to learn about the field from key opinion leaders and will present a fantastic platform for networking with senior executives from the pharmaceutical industry.
Key topics to be addressed:
• Cognition enhancement
• Latest developments in MS, PD and AD clinical development
• Biomarkers and CNS clinical trials
• Participant recruitment and retention issues in CNS clinical trials
• Schizophrenia and depression: specific considerations.
• Efficacy predictions
• Current challenges in translational CNS research
• Facilitating and establishing industry and academic partnering
• Early phase development trials in CNS
Hear keynote addresses from:
• Hitendra Parmar, European Medical Director for Alzheimer's Disease, Pfizer
• Georg Terstappen, Director and Department Head, Neuroscience Discover, Abbott
• Sophie Dix, Senior Research Scientist, Neurodegenerative Diseases Drug Hunting Team, Lilly
• Florien von Raison, Head of Global Clinical Development Unit, Parkinson's Diseases, Merck Serono
• Chas Bountra,Chief Scientist, Structural Genomics Consortium, Univeristy of Oxford
• Simon Ridley, Head of Research, Alzheimer's Research UK
Visit http://www.smi-online.co.uk/2011cnstrials36.asp to reserve your place. Alternatively, contact Asma Bibi at Tel: +44 (0) 207 827 6736 or
Email: abibi@smi-online.co.uk.
About SMi Group
Clinical Trials in CNS is just one of the many conferences that are a part of the SMi Group portfolio.
The SMi Group is a world leader in business to business information. With nearly two decades in the business, thousands of senior executives from blue chip companies have already benefitted from SMi's highly targeted conferences, workshops and publications. For more information visit www.smi-online.co.uk
For further information, contact:
Asma Bibi
Tel: +44 (0) 207 827 6736
Email: abibi@smi-online.co.uk
This conference will focus on a wide range of therapeutic areas such as Multiple Sclerosis, Parkinson's and Alzheimer's, as well as considering a multitude of psychiatric disorders with in-depth discussions and case study presentations from the key industry players.
As such a fast-progressing and important field, it is vital that you are kept up to date with the latest developments and advances in CNS Clinical Trials, such as novel translational research studies. This conference will offer a unique opportunity for you to learn about the field from key opinion leaders and will present a fantastic platform for networking with senior executives from the pharmaceutical industry.
Key topics to be addressed:
• Cognition enhancement
• Latest developments in MS, PD and AD clinical development
• Biomarkers and CNS clinical trials
• Participant recruitment and retention issues in CNS clinical trials
• Schizophrenia and depression: specific considerations.
• Efficacy predictions
• Current challenges in translational CNS research
• Facilitating and establishing industry and academic partnering
• Early phase development trials in CNS
Hear keynote addresses from:
• Hitendra Parmar, European Medical Director for Alzheimer's Disease, Pfizer
• Georg Terstappen, Director and Department Head, Neuroscience Discover, Abbott
• Sophie Dix, Senior Research Scientist, Neurodegenerative Diseases Drug Hunting Team, Lilly
• Florien von Raison, Head of Global Clinical Development Unit, Parkinson's Diseases, Merck Serono
• Chas Bountra,Chief Scientist, Structural Genomics Consortium, Univeristy of Oxford
• Simon Ridley, Head of Research, Alzheimer's Research UK
Visit http://www.smi-online.co.uk/2011cnstrials36.asp to reserve your place. Alternatively, contact Asma Bibi at Tel: +44 (0) 207 827 6736 or
Email: abibi@smi-online.co.uk.
About SMi Group
Clinical Trials in CNS is just one of the many conferences that are a part of the SMi Group portfolio.
The SMi Group is a world leader in business to business information. With nearly two decades in the business, thousands of senior executives from blue chip companies have already benefitted from SMi's highly targeted conferences, workshops and publications. For more information visit www.smi-online.co.uk
For further information, contact:
Asma Bibi
Tel: +44 (0) 207 827 6736
Email: abibi@smi-online.co.uk
Follow us
What people say
“We have generated many, many press clippings and improved our SEO ranking from the services that EIN Presswire provides us. Easy and simple way to upload and distribute our press releases. I would recommend their services.”
— Chris Morris, Marketing Manager of Mountz Inc.
“I have been using the EIN Press Release service for more than three years in entertainment & health care industries. Their account managers and the placement of my press releases online has been above reproach reaching mainstream journalists to help further client and brand visibility. I highly recommend this service for global notoriety and am thankful I made that first call.“
— Monica Anders PR Strategist 25 Years!
Our Partners
Press releases
- Web Marketing Association Names Best Mobile Web Sites and Best Mobile Apps of 2012 [23 May 2012] PR Newswire
- QuickMobile Launches New Analytics Dashboard to Equip Event Marketers with Real-Time Mobile Data [23 May 2012] PR Newswire
© 2005-2012